She underwent biopsy of a left groin nodule and the skin nodule revealing melanoma and was diagnosed with metastatic melanoma.
She was subsequently transferred to [**Hospital1 69**] on [**2121-2-13**] for further management.
On admission, her back pain was managed with MS Contin with p.r.n.
Treatment options were discussed and high-dose IL-2 therapy was recommended.
She initiated high-dose IL-2 on [**2121-2-15**] after undergoing central line placement in interventional radiology.
She was managed with oxygen supplementation and aggressive Lasix diuresis as well as albuterol nebulizers.
Her respiratory status worsened over the next 36 hours, requiring ICU transfer for aggressive diuresis and fluid management.
She was treated with antibiotics for a possible pneumonia.
She slowly improved with Lasix diuresis and was transferred out of the ICU on [**2121-2-26**] and was able to be discharged to home later that day when ambulating off O2 without noted hypoxia.
Other side effects during this week included rigors improved with Demerol; nausea improved with antiemetic therapy; normal sinus tachycardia and development of an erythematous skin rash.
She was anemic without need for packed red blood cell transfusion.
DISCHARGE MEDICATIONS:  Tylenol 1-2 tablets q.i.d.
pain, Zantac 150 mg p.o.
indigestion, lorazepam 0.521 mg t.i.d.
nausea/vomiting or anxiety, Benadryl 25-50 mg q.i.d.
pruritus, Compazine 10 mg q.i.d.
diarrhea, Eucerin cream topically, Sarna lotion topically, MS Contin 15 mg p.o.
constipation, oxycodone 5-10 mg every 4 hours p.r.n.
pain, guaifenesin [**4-21**] mL p.o.
cough, nicotine patch 21 mg topically every 24 hours, levofloxacin 500 mg p.o.
